Not estimable in the model [BE/BA News]

posted by The user – Russia, 2017-03-14 13:13 (2156 d 08:52 ago) – Posting: # 17154
Views: 21,603

❝ Try a type I model with Group before Subjects, then you'll get something that is estimable, I believe.


Thank you for your reply.

Sorry, but I did not catch the idea. Should I try this model: Group+Patient(Sequence)+Sequence+Period+Treatment?

One more comment: the groups are unbalanced. Type I is suiatable for balanced groups as I undertood. Looks like I could not use the Type I model.

Complete thread:

UA Flag
Activity
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
12 visitors (0 registered, 12 guests [including 6 identified bots]).
Forum time: 22:06 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5